Advances from targeted therapy for non-metastatic HER2-positive inflammatory breast cancer. Steadman JA, Hieken TJ. J Surg Oncol 2024 Aug 5. doi: 10.1002/jso.27797.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Steadman JA, Hieken TJ. Advances from targeted therapy for non-metastatic HER2-positive inflammatory breast cancer. J Surg Oncol 2024 Aug 5. doi: 10.1002/jso.27797.
PMID: 39101322